{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:08:26Z","timestamp":1792516106426,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijpharm.2023.123748","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T02:03:38Z","timestamp":1703556218000},"page":"123748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Enhanced the treatment of ischemic stroke through intranasal temperature-sensitive hydrogels of edaravone and borneol inclusion complex"],"prefix":"10.1016","volume":"651","author":[{"given":"Chuanhui","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2966-7381","authenticated-orcid":false,"given":"Hongliang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2023.123748_b0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.foodchem.2015.10.023","article-title":"Characterization of beta-cyclodextrin inclusion complexes containing an essential oil component","volume":"196","author":"Abarca","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.ijpharm.2023.123748_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.foodchem.2017.04.095","article-title":"Antibacterial electrospun zein nanofibrous web encapsulating thymol\/cyclodextrin-inclusion complex for food packaging","volume":"233","author":"Aytac","year":"2017","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.ijpharm.2023.123748_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbadis.2018.09.012","article-title":"Current advances in ischemic stroke research and therapies","volume":"1866","author":"Barthels","year":"2020","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.ijpharm.2023.123748_b0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/svn-2021-001032","article-title":"Mechanisms of fibrinolysis resistance and potential targets for thrombolysis in acute ischaemic stroke: lessons from retrieved stroke emboli","volume":"6","author":"Brinjikji","year":"2021","journal-title":"Stroke Vasc. Neurol."},{"issue":"10","key":"10.1016\/j.ijpharm.2023.123748_b0025","first-page":"2124","article-title":"Effect of plasma fibrinogen level-based defibrase therapy in patients with acute cerebral infarction","volume":"29","author":"Cai","year":"2009","journal-title":"Nan fang yi ke da xue xue bao = J. Southern Med. Univ."},{"issue":"2","key":"10.1016\/j.ijpharm.2023.123748_b0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamaneurol.2020.4123","article-title":"Association of reperfusion after thrombolysis with clinical outcome across the 4.5-to 9-hours and wake-up stroke time window a meta-analysis of the EXTEND and EPITHET randomized clinical trials","volume":"78","author":"Campbell","year":"2021","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.ijpharm.2023.123748_b0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7555\/JBR.31.20160138","article-title":"(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines","volume":"31","author":"Chang","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.ijpharm.2023.123748_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2019\/2936737","article-title":"Borneol for regulating the permeability of the blood-brain barrier in experimental ischemic stroke: preclinical evidence and possible mechanism","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123748_b0045","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.3390\/ijms14036499","article-title":"Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis","volume":"14","author":"Chu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijpharm.2023.123748_b0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1474-4422(19)30043-2","article-title":"Stroke genetics: discovery, biology, and clinical applications","volume":"18","author":"Dichgans","year":"2019","journal-title":"Lancet Neurol."},{"issue":"15","key":"10.1016\/j.ijpharm.2023.123748_b0055","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","article-title":"Primary and secondary prevention of ischemic stroke and cerebral hemorrhage","volume":"75","author":"Diener","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijpharm.2023.123748_b0060","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D'souza","year":"2016","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.ijpharm.2023.123748_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118925","article-title":"Design of a dual pH and temperature responsive hydrogel based on esterified cellulose nanocrystals for potential drug release","volume":"278","author":"Emam","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2023.123748_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erdo","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123748_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"Ganger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2023.123748_b0080","article-title":"Anticoagulants for acute ischaemic stroke","volume":"2","author":"Gubitz","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123748_b0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acsami.6b13805","article-title":"Enhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticles","volume":"9","author":"Jiang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.ijpharm.2023.123748_b0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ijpharm.2023.123748_b0095","first-page":"1167","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cell. Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2023.123748_b0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijpharm.2023.123748_b0105","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1161\/STROKEAHA.115.008226","article-title":"Global stroke belt geographic variation in stroke burden worldwide","volume":"46","author":"Kim","year":"2015","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.ijpharm.2023.123748_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms21207609","article-title":"Pathophysiology and treatment of stroke: present status and future perspectives","volume":"21","author":"Kuriakose","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2023.123748_b0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/STROKEAHA.118.023317","article-title":"Public awareness of stroke and the appropriate responses in China a cross-sectional community-based study (FAST-RIGHT)","volume":"50","author":"Li","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.ijpharm.2023.123748_b0120","first-page":"23","article-title":"Progress in borneol intervention for ischemic stroke: a systematic review","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123748_b0125","first-page":"341","article-title":"Free radical scavenging mechanism of edaravone and its clinical application","volume":"16","author":"Liping","year":"2011","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2023.123748_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2021.105627","article-title":"Borneol in cardio-cerebrovascular diseases: pharmacological actions, mechanisms, and therapeutics","volume":"169","author":"Liu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpharm.2023.123748_b0135","doi-asserted-by":"crossref","DOI":"10.1039\/C9BM01354G","article-title":"H2O2-activated oxidative stress amplifier capable of GSH scavenging for enhancing tumor photodynamic therapy","author":"Liu","year":"2019","journal-title":"Biomater. Sci."},{"issue":"12","key":"10.1016\/j.ijpharm.2023.123748_b0140","doi-asserted-by":"crossref","first-page":"E897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990\u20132019: an analysis for the Global Burden of Disease Study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ijpharm.2023.123748_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.foodchem.2013.12.067","article-title":"Curcumin-beta-cyclodextrin inclusion complex: Stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application","volume":"153","author":"Mangolim","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.ijpharm.2023.123748_b0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molliq.2017.04.098","article-title":"Inclusion complex of antiasthmatic compound with 2-hydroxypropyl-beta-cyclodextrin: preparation and physicochemical properties","volume":"237","author":"Ol'khovich","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2023.123748_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.ijpharm.2023.123748_b0160","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2174\/1570159X16666180302115544","article-title":"Cell death mechanisms in stroke and novel molecular and cellular treatment options","volume":"16","author":"Sekerdag","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ijpharm.2023.123748_b0165","doi-asserted-by":"crossref","unstructured":"Vidal, S.M., Chaudhry, F.S., Schneck, M., 2013. Management of acute ischemic stroke. Hosp. Pract. (1995). 41(2), 108\u2013122.","DOI":"10.3810\/hp.2013.04.1060"},{"issue":"9","key":"10.1016\/j.ijpharm.2023.123748_b0170","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijpharm.2023.123748_b0175","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1089\/neu.2011.1939","article-title":"Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats","volume":"28","author":"Wang","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.ijpharm.2023.123748_b0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","article-title":"How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?","volume":"62","author":"Watanabe","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"6","key":"10.1016\/j.ijpharm.2023.123748_b0185","first-page":"553","article-title":"Report on Cardiovascular Health and Diseases in China 2021: an Updated Summary","volume":"37","year":"2022","journal-title":"Chin. Circul. J."},{"key":"10.1016\/j.ijpharm.2023.123748_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111581","article-title":"Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy","volume":"200","author":"Xiao","year":"2021","journal-title":"Colloids Surf. B-Biointerfaces"},{"issue":"3","key":"10.1016\/j.ijpharm.2023.123748_b0195","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","article-title":"Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke a Phase III, randomized, double-blind, comparative trial","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ijpharm.2023.123748_b0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41565-020-00843-7","article-title":"Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection","volume":"16","author":"Zhang","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.ijpharm.2023.123748_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092761","article-title":"Preparation and properties of cyclodextrin inclusion complexes of hyperoside","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijpharm.2023.123748_b0210","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5070","article-title":"Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)","volume":"49","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Med."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:38:25Z","timestamp":1759919905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517323011705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":42,"alternative-id":["S0378517323011705"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123748","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced the treatment of ischemic stroke through intranasal temperature-sensitive hydrogels of edaravone and borneol inclusion complex","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123748"}}